Compare Enveric Biosciences Inc (ENVB) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while Direxion Daily TSLA Bull 2X Shares trades at $11.98. The key difference: Direxion Daily TSLA Bull 2X Shares is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | TSLL | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $17.40 | $23.03 |
52-Week Low | $1.28 | $10.29 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
TSLL is trading at $11.879, down 3.81% on the day, with a bearish technical outlook indicated by moving averages. The stock shows oversold conditions on short-term RSI. Recent news highlights its connection to Tesla and leveraged-inverse ETF strategies. Key financial ratios are unavailable, limiting fundamental clarity.
The outlook is cautious due to technical weakness and lack of current financial data. Investment opportunity hinges on Tesla's performance and ETF demand, but risks include high volatility and dependency on underlying assets. Investors need updated fundamentals for a clear assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
